Clinical-stage immuno-oncology company Agenus (NASDAQ:AGEN) recently executed a 1-for-20 reverse stock split to give the ...

The project is aimed at developing novel approaches to enhance tumor immunogenicity to broaden the population of patients who ...

Many people have heard of FIV-positive cats, but don't really understand what that means. Feline Immunodeficiency Virus is ...

One of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000 square-foot research facility in ...

Join 400+ leaders, experts, and researchers at Immuno 2024, connecting pharmaceutical and biotech representatives as well as academia for high-level discussions on the latest innovations in ...

As a new parent, you’re embarking on a life changing journey – one filled with adorable baby giggles, sleepless nights, and whole lot of questions. To make things easier, we’ve developed some articles ...

—These quiz questions about issues relevant to the immuno-oncology payer community are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those ...

Jeffrey Glazer expressed his enthusiasm about the collaboration, saying, "This exclusive licensing agreement with Georgetown University marks a pivotal moment for Aubex Therapeutics. ATX100 has ...

Planegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell ...